Category: Peer-reviewed

A Simple Vista en Este Número

En un informe del Estudio Multicentro de Tratamiento de Uveítis con Esteroides (MUST), Friedman y otros (p. 1571) analizaron la incidencia a 2 años de aumento de la presión intraocular (IOP) y daño del nervio óptico en pacientes con uveítis poste…

Reply

We would like to thank Dr Sharma and his associates for their interest in our paper. We also appreciate them for noticing the typographical errors in our paper. They noted that the logMAR values reported in Table 5 should have been written as positive…

Reply

We thank Chhablani and associates for their interest in our article and their comments, which mainly concern the methodology of our study. They expressed concern that some of our patients with intermittent exotropia may have a normal range of ocular to…

Reply

I thank Lyons for his comments and for alluding to Marmor’s editorial, providing an opportunity to respond to both. His first concern is that the use of hydroxychloroquine not be halted without good cause. One can understand this concern based on the s…

Reply

We appreciate the interest and comments by Dr Eggenberger in regard to our recent article examining the incidence of optic neuritis in patients using anti–tumor necrosis factor therapies. His letter highlights many important aspects of our paper and …

Essentials of Glaucoma Surgery

Media Type: Textbook (paperback). Synopsis: Glaucoma surgery is a complex subject to address fully with the inherent challenges of multiple surgical variations used in clinical practice. Dr Malik Kahook, an accomplished and innovative academic glauco…

Reply

We thank Galvis and associates for their interest in our article and their thoughtful comments. They suggested that the amount of change in corneal higher-order aberrations with age is less than that in total ocular higher-order aberrations, and cornea…

Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After Laser In Situ Keratomileusis: A Prospective Randomized Clinical Trial

We perused with great interest the randomized controlled trial by Shojaei and associates, which studied the effect of timolol eye drops in refractive outcomes in eyes with myopic regression after laser in situ keratomileusis (LASIK). In this trial, the authors compared the outcomes of treating patients presenting with myopic regression following LASIK with timolol eye drops instilled twice a day to treatment by instilling artificial tear drops in an identical regime as placebo. The spherical equivalent was significantly better in the timolol (treatment) arm 6 months after treatment, and also 6 months after discontinuation of treatment (P < .001 for both comparisons). Based on these results, the authors concluded that instillation of timolol eye drops is effective for the treatment of myopic regression after LASIK and its effect seems to last for at least 6 months after discontinuation. The study design and statistical analysis were appropriate, but we do have the following observations to make.